France's Sanofi-Aventis SA, meanwhile, is carrying out large clinical trials of an oral MS drug called teriflunomide.
法国制药公司赛诺菲-安万特同时也在就自己的治疗多发性硬化症的口服药物teriflunomide的大型临床试验。
The product is already marketed in Europe, Australia and Canada by Sanofi Pasteur, the vaccine division of French drug giant Sanofi, previously known as Sanofi-Aventis SA.
赛诺菲巴斯德公司已在欧洲、澳大利亚和加拿大上市销售该产品。
应用推荐